(Q41553589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Trevor Sharp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

S M Le Corre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Meller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P J Harrison

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

Neurochemistry International

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

349-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

Modified oligonucleotides as therapeutic and diagnostic agents

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Cellular uptake and intracellular fate of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

In vivo antisense inhibition of prodynorphin expression in rat striatum: dose-dependence and sequence specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Oligonucleotides as research, diagnostic, and therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense: into the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense as an explanatory, experimental and therapeutic tool for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Application of antisense technology to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Implication of RNA structure on antisense oligonucleotide hybridization kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Current concepts in antisense drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligonucleotides in the study of neuroendocrine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Reduction in muscarinic receptors by antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900106-4

7 January 2021

10.1016/S0197-0186(96)00106-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246678%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference